Mullein's Antiviral Properties

Table of Contents

  1. Overview of Mullein Antiviral Research
  2. Activity Against Herpes Simplex Virus (HSV-1)
  3. Activity Against Influenza Virus and Reported Amantadine Synergy
  4. The Pseudorabies Virus Study and Mode of Action
  5. Verbascoside (Acteoside) as a Key Antiviral Constituent
  6. Proposed Mechanisms of Antiviral Activity
  7. In-Vitro Promise vs Clinical Reality
  8. Traditional Use During Respiratory Infections
  9. How Mullein Is Used in This Context
  10. Safety and Sensible Expectations
  11. Research Papers and References
  12. Connections
  13. Featured Videos

Overview of Mullein Antiviral Research

Common mullein (Verbascum thapsus) is best known as a soothing respiratory herb, but a smaller and frequently overlooked thread of the scientific literature examines its antiviral activity. Interest in this property is not new — folk practitioners across Europe and North America reached for mullein leaf and flower preparations during coughs, colds, and feverish illnesses long before anyone could identify a virus under a microscope. Modern laboratory work has tried to put that traditional reputation on a measurable footing by testing mullein extracts against specific, well-characterized viruses in cell culture.

The evidence base is modest but genuinely interesting. Mullein appears in at least one influential screening study of medicinal plants for antiviral activity, and a dedicated study has examined a methanolic extract's effect on a model herpesvirus. Several of the herb's individual constituents — most prominently the phenylethanoid glycoside verbascoside (also called acteoside) — have independent antiviral data in the broader phytochemistry literature. Taken together, these threads suggest a plausible biological basis for mullein's traditional use in viral respiratory illness, while falling well short of proof that drinking mullein tea treats any specific viral infection in humans.

This article walks through what has actually been measured: the herpes simplex and influenza screening data, the pseudorabies virus study and its proposed mode of action, the role of verbascoside, and the mechanisms researchers have proposed. It then draws an honest line between the laboratory findings and clinical reality, because the gap between "active in a dish" and "effective in a person" is the single most important thing to understand about herbal antivirals.

Back to Table of Contents

Activity Against Herpes Simplex Virus (HSV-1)

One of the most frequently cited pieces of evidence for mullein's antiviral potential comes from a broad screening study of British Columbian medicinal plants. McCutcheon and colleagues (published in the Journal of Ethnopharmacology in 1995) tested extracts of a large number of plants used by indigenous peoples of British Columbia for activity against several viruses, including herpes simplex virus type 1 (HSV-1). Within this screen, Verbascum thapsus was among the species reported to show measurable antiviral activity, which is one reason the herb continues to be mentioned in antiviral phytochemistry reviews decades later.

It is worth being precise about what a screening study like this does and does not establish. These experiments are performed in vitro — extracts are applied to cultured cells that are then exposed to virus, and researchers look for a reduction in the cytopathic (cell-damaging) effect the virus would otherwise produce. A positive signal means the extract interfered with viral infection or replication under those specific laboratory conditions. It does not, by itself, tell us the active compound, the effective dose in a living organism, whether the compound reaches the relevant tissues when the herb is consumed, or whether the effect translates into any clinical benefit.

Nonetheless, the McCutcheon screen is meaningful because it was systematic and comparative: many plants were tested side by side under the same conditions, and mullein registered as one of the active species against herpesviruses. That places it in reasonable scientific company with other traditionally used antiviral botanicals and provides a rational starting point for the more detailed mechanistic work that followed.

Back to Table of Contents

Activity Against Influenza Virus and Reported Amantadine Synergy

Because mullein's traditional reputation centers on respiratory illness, its activity against influenza virus is of particular interest. Several phytochemical reports have examined Verbascum extracts and isolated constituents for anti-influenza activity in cell culture, and the herb is repeatedly listed among plants with reported activity against influenza A in antiviral plant reviews. The proposed antiviral constituents overlap with those credited for the herpesvirus activity — chiefly the phenylethanoid glycosides such as verbascoside.

A particularly intriguing observation reported in the literature is that mullein extract has shown synergy with amantadine against influenza in vitro — meaning the combination produced a greater inhibitory effect than either agent alone at the same concentrations. Amantadine is a synthetic antiviral that targets the influenza A M2 ion channel. If a plant extract enhances its activity in a dish, that hints the extract is acting through a complementary mechanism (for example, interfering with viral entry or an early replication step rather than the M2 channel). This kind of synergy is scientifically interesting because it can, in principle, allow lower drug doses or help against partially resistant strains.

Two cautions apply. First, amantadine resistance in circulating human influenza A strains is now widespread, so the clinical drug itself is no longer first-line for seasonal flu — which limits the practical relevance of any amantadine-combination finding. Second, in-vitro synergy does not establish that drinking mullein tea while taking an antiviral does anything useful or safe in a human being. The finding is best read as a mechanistic clue that mullein constituents engage influenza biology through a route distinct from the M2 channel, not as a treatment recommendation.

Back to Table of Contents

The Pseudorabies Virus Study and Mode of Action

The most mechanistically detailed antiviral study of mullein examined a methanolic extract of Verbascum thapsus against pseudorabies virus (PRV, strain RC/79). Pseudorabies is an alphaherpesvirus of swine and is widely used as a laboratory model for the herpesvirus family because it is well characterized, grows readily in cell culture, and shares core replication machinery with human herpesviruses. Using a herpesvirus model also makes this study a useful complement to the earlier HSV-1 screening signal.

The study reported that the methanolic mullein extract exerted a measurable antiviral effect against PRV and, importantly, attempted to characterize when in the viral life cycle the extract acts — its "mode of action." Time-of-addition and virus-versus-cell pretreatment experiments are the standard way to localize antiviral activity: an extract can act by directly inactivating virus particles before they reach a cell (a virucidal effect), by blocking attachment or entry, by protecting the host cell, or by interfering with intracellular replication after entry. Distinguishing among these possibilities is what separates a careful mechanistic study from a simple yes/no screen.

The practical value of the pseudorabies work is twofold. It independently corroborates that mullein extracts have reproducible activity against a herpesvirus, and it begins to explain how — pointing toward interference with early steps of infection rather than a non-specific toxic effect on the host cells. That distinction matters, because an extract that merely kills the cells it is added to would register as "antiviral" in a crude assay while being useless (and harmful) as a therapy. A defined mode of action against the virus itself is far more promising.

Back to Table of Contents

Verbascoside (Acteoside) as a Key Antiviral Constituent

When researchers ask which molecule is responsible for mullein's antiviral signal, attention repeatedly lands on verbascoside, a phenylethanoid (phenylpropanoid) glycoside also widely known as acteoside. Verbascoside is abundant in Verbascum species — the genus name is the source of the compound's common name — and it is one of the herb's most pharmacologically studied constituents, with documented antioxidant and anti-inflammatory activity in addition to its reported antiviral effects.

In the broader phytochemistry literature (independent of mullein specifically), verbascoside has been reported to inhibit several viruses in cell culture and to interfere with viral enzymes and entry steps. Because verbascoside occurs in many medicinal plants beyond mullein, this body of work is larger than the mullein-specific data and lends mechanistic plausibility to the idea that mullein's antiviral signal is, at least in part, a verbascoside effect. Mullein also contains other potentially relevant constituents — flavonoids, iridoid glycosides such as aucubin, and saponins — some of which have their own antimicrobial and antioxidant reputations, so the herb's overall activity is likely a composite rather than the work of a single molecule.

The caveat familiar from any whole-herb discussion applies here too: the concentration of verbascoside delivered by a cup of mullein tea, and how much of it survives digestion and reaches the bloodstream or respiratory tissues, is not well established and almost certainly differs from the purified-compound concentrations used in laboratory assays. Demonstrating that an isolated constituent inhibits a virus in a dish is a necessary step, but it is not the same as showing that the whole-herb preparation people actually drink delivers a therapeutic amount of that constituent to the right place.

Back to Table of Contents

Proposed Mechanisms of Antiviral Activity

Across the herpesvirus and influenza studies, a few recurring mechanistic themes emerge for how mullein constituents may interfere with viruses. None is definitively proven for the whole herb in humans, but each is grounded in the kind of in-vitro evidence described above and in the general pharmacology of phenylethanoid glycosides and flavonoids.

The likeliest honest summary is that mullein acts through a combination of these routes, with different constituents contributing to different effects, and with the early-entry and host-soothing mechanisms best supported by the available data. What is not supported is any claim of a single, potent, drug-like antiviral action in the body.

Back to Table of Contents

In-Vitro Promise vs Clinical Reality

This is the section that matters most, and it deserves plain language. Essentially all of the antiviral evidence for mullein is in vitro — it comes from experiments in cell culture, not from controlled trials in people. The McCutcheon herpes screen, the influenza and amantadine-synergy observations, the pseudorabies mode-of-action study, and the verbascoside data are all laboratory findings. There are, at present, no robust human clinical trials demonstrating that mullein tea, tincture, or capsules cure or shorten any viral infection — whether a cold, the flu, a cold sore, or anything else.

The reason this distinction is non-negotiable is that the laboratory and the body are very different environments. In a dish, a known concentration of extract sits in direct contact with infected cells for the entire experiment. In a person, the herb must be absorbed from the gut, survive first-pass metabolism in the liver, distribute through the bloodstream, and arrive at the infected tissue at a concentration high enough to matter — all while being continuously cleared. Many compounds that look impressive in a dish achieve only a tiny fraction of the active concentration in human tissues, which is precisely why the great majority of in-vitro antiviral "hits" never become medicines.

So the accurate framing is this: mullein has a plausible, traditionally-anchored, laboratory-supported antiviral profile, and that is a legitimate reason it has been used during respiratory infections for centuries. It is not a proven antiviral treatment, and it should never be used in place of vaccination, antiviral medication, or medical care for a serious or persistent infection. Treating mullein as a comforting adjunct that may ease symptoms is reasonable; treating it as a cure is not supported by the evidence.

Back to Table of Contents

Traditional Use During Respiratory Infections

Long before viruses were understood, mullein occupied a settled place in the herbal medicine cabinets of Europe and, later, North America for exactly the kinds of illnesses we now know are often viral: coughs, colds, sore throats, bronchitis, and feverish "catarrhal" complaints. The leaves and bright yellow flowers were brewed into teas, simmered into syrups, and infused into oils. This traditional reputation is the historical reason researchers thought to test the herb against viruses in the first place — the laboratory work is, in a sense, modern science checking an old folk hypothesis.

Much of mullein's traditional usefulness in respiratory illness is plausibly explained by its demulcent (soothing, mucus-membrane-coating) and expectorant properties rather than by direct virus-killing. The saponins and mucilage in the leaf help loosen and move mucus and soothe an irritated, inflamed airway lining, which can make a viral cough genuinely more bearable even if the herb has no meaningful effect on viral replication in the body. In other words, the herb may help you feel better during a viral illness through symptom relief, which is a real and valuable effect, while the question of whether it shortens the infection itself remains unproven.

This reading also reconciles the folk record with the science. A remedy can earn a multi-century reputation for being helpful during colds and flu purely by easing cough, soothing the throat, and reducing irritation — it does not need to be a true antiviral to be valued. The in-vitro antiviral data add an intriguing extra dimension, but the core of mullein's traditional respiratory use is comfort and symptom relief.

Back to Table of Contents

How Mullein Is Used in This Context

People reaching for mullein during a viral respiratory illness typically use one of a few simple preparations. None of these should be regarded as a treatment for the infection itself — they are traditional comfort measures that may help with cough and throat irritation while the body clears the virus.

Because there are no clinical trials, there is no evidence-based "antiviral dose" of mullein. People generally follow standard culinary-tea amounts (roughly 1–2 teaspoons of dried herb per cup, a few cups daily during illness) and the directions on commercial products. Anyone using mullein during an infection should still pursue appropriate medical care, hydration, and rest — the herb is a comfort measure, not a substitute for treatment.

Back to Table of Contents

Safety and Sensible Expectations

Mullein leaf and flower preparations have a long traditional record of use and are generally considered well tolerated when used appropriately. Still, a few sensible precautions apply, especially in the context of fighting off an infection.

The reasonable expectation for mullein during a viral illness is symptom comfort — a soothed throat and an easier cough — supported by centuries of traditional use, with an intriguing but unproven laboratory hint of direct antiviral action layered on top. Held to that honest standard, mullein is a gentle and time-honored ally during respiratory infection; held to the standard of a curative antiviral drug, it simply has not been shown to work.

Back to Table of Contents

Research Papers and References

The references below combine the small number of directly relevant peer-reviewed studies with curated PubMed topic-search links into the broader literature on Verbascum thapsus, verbascoside, and herbal antivirals. Where a specific paper is hardcoded, the link resolves to that record or a precise PubMed search; the remaining entries open live PubMed searches at the National Library of Medicine.

  1. McCutcheon AR, et al. (1995). Antiviral screening of British Columbian medicinal plants. Journal of Ethnopharmacology; 49(2):101–110. — PubMed
  2. Antiviral effect and mode of action of methanolic extract of Verbascum thapsus L. on pseudorabies virus (strain RC/79). — PubMed (PMID 21999656)
  3. Turker AU, Gurel E (2005). Common mullein (Verbascum thapsus L.): recent advances in research. Phytotherapy Research; 19(9):733–739. — DOI: 10.1002/ptr.1653
  4. Verbascum thapsus (mullein) phytochemistry and pharmacology review. Phytotherapy Research. — DOI: 10.1002/ptr.7393
  5. Verbascum thapsus and influenza antiviral activity. — PubMed search
  6. Verbascoside (acteoside) antiviral activity. — PubMed search
  7. Acteoside antiviral mechanism and viral enzyme inhibition. — PubMed search
  8. Verbascum thapsus herpes simplex virus activity. — PubMed search
  9. Verbascum thapsus antiviral constituents and phenylethanoid glycosides. — PubMed search
  10. Mullein (Verbascum thapsus) respiratory and antimicrobial uses. — PubMed search

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents